In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

VaxGen Inc.

Division of Diadexus Inc.
www.vaxgen.com

Latest From VaxGen Inc.

FDA Confirmation Watch: Gottlieb Likely To Face Questions About Approval Standards, Ties To Industry

Top HELP Committee Democrat Patty Murray tweeted concerns about Gottlieb's positions on the "gold standard" of FDA approval; Pubic Citizen's Michael Carome ultimately thinks Gottlieb will be approved.

FDA Leadership

US FDA Commissioner Confirmation: Gottlieb To Get Questions On Approval Standards, Ties To Industry

Top Senate committee Democrat Patty Murray tweeted concerns about Gottlieb's positions on 'gold standard' of FDA approval; Public Citizen's Michael Carome ultimately thinks Gottlieb will be approved.

Leadership Regulation

Scrip 100: Despite advances, we still need an HIV vaccine

The fact that the AIDS pandemic has faded from the news agenda in recent years is a reflection of the perception, in the developed world at least, of HIV disease as a chronic, manageable condition. No longer is the pandemic seen as the threat it once was. So does that mean the AIDS battle is being won?

Immune Disorders Infectious Diseases

Obama pledges $5bn to AIDS fund, directs $100m to NIH for cure

To ensure scientific breakthroughs for HIV/AIDS are continued to be pursued, President Barack Obama on 2 December pledged $5bn to the Global Fund to Fight AIDS, Tuberculosis and Malaria and said his administration was redirecting $100m to the National Institutes of Health (NIH) toward finding a cure for HIV.

Immune Disorders Infectious Diseases
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Genevax Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Diadexus Inc.
  • Senior Management
  • James P Panek, Pres.
  • Contact Info
  • VaxGen Inc.
    Phone: (650) 624-1000
    379 Oyster Point Blvd.
    South San Fransisco, CA 94080
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register